Barinthus Biotherapeutics (BRNS) Invested Capital (2021)
Barinthus Biotherapeutics' (BRNS) quarterly Invested Capital came in at $159000.0 in Q4 2021.
Barinthus Biotherapeutics (BRNS) Invested Capital (2021) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 1 years of Invested Capital data on file, last reported at $159000.0 in Q4 2021.
- Quarterly Invested Capital changed N/A year-over-year to $159000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $159000.0 (changed N/A YoY) and the FY2021 annual result came in at $159000.0, changed N/A from the prior year.
- Invested Capital was little changed at $159000.0 in Q4 2021.
- In the past five years, Invested Capital ranged from a high of $159000.0 in Q4 2021 to a low of $159000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Barinthus Biotherapeutics | 25.40 Mn | 25.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 159,000.00 |